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Despite the availability of treatment that is effective, Trichomonas vaginalis infections are
still high. A deterministic model for transmission dynamics of Trichomonas vaginalis is
presented as a system of non-linear differential equations. Analysis of the reproduction
number has shown that an increase in the number of straight women (non-lesbians)
infected result in an increase in the number of lesbians infected. This suggests that straight
women are turning into lesbians already infected. The disease-free equilibrium is shown to
be globally asymptotically stable when the corresponding reproduction number is less than
unity. Analytical results and numerical simulations both show that treatment is able to
control Trichomonas vaginalis infections. This suggests an effective control of trichomoniasis
rests in encouraging and persuading sexual partners of those displaying symptoms to seek
treatment. Failure for the asymptomatic to seek treatment (mostly males given that the
majority of males does not show symptoms) will continue to fuel the infection.
© 2011 Elsevier Inc. All rights reserved.
1. Introduction
Trichomonas vaginalis also called trichomoniasis is one of the commonest sexually transmitted pathogens in the world
with an estimated 174 million cases occurring each year [33]. It is a far more prevalent sexually transmitted infection than
either Chlamydia trachomatis or Neisseria gonorrhoeae, yet in stark contrast little attention is paid to trichomoniasis [26]. In
the United States, it was recently estimated that 5 million new cases appear annually [27,33,7,10] compared with 3 million
cases of chlamydia and 650000 cases of gonorrhea annually. The epidemiology of the disease is still poorly understood and
some practitioners continue to question its importance [3]. Trichomanas vaginalis is more prevalent in females (67%–100%
female sexual partners of infected man get infected) than in males (14%–60% of male sexual partners of an infected woman
get infected) [1,16,13]. The reason why females are more infected is poorly understood, although some researchers [17,9]
think the prostatic ﬂuid contains zinc and other substances harmful to the pathogen.
In females trichomoniasis is associated with vaginal discharge, vaginal itching, pain when urinating and up to one-
third of women do not show symptoms [15]. Although most males do not show symptoms related to Trichomanas vaginalis
infection, some do experience urethral discharge, pain when urinating and swelling of the scrotum [15]. Usually treatment
consists of metronidazole and tinidazole. Left untreated chronic Trichomanas vaginalis infections may lead to complications
including: pelvic inﬂammatory disease, premature rapture of membranes, low-birth-weight infants, pre-term delivery and
abortion [29,21,5]. Cudmore and Garber [8] showed that the development of a vaccine against Trichomanas vaginalis could
reduce the human costs (pregnancy complications, infertility), medical costs and increased susceptibility to HIV and societal
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[18,11,21,14].
Malaria, Tuberculosis, Hepatitis B, HIV/AIDS and other sexually transmitted infections have all being mathematically
accounted for (see [28,2,24,31,22,25] to mention just a few of them). Quite recently some authors [34,19] did analyse some
general SIR and SEIRS models with interesting dynamics. The later [19] did analyse SEIRS model incorporating multiple
infectious stages. Despite Trichomanas vaginalis being an old infection which is still affecting mankind no mathematical
account of it has been carried out to the best knowledge of the authors. Here we attempt to give mathematical analysis
of it taking into consideration effects of differential infectivity patterns between males and females as well as between
lesbians and non-lesbians. To the best of the author this may be the ﬁrst manuscript to look into these aspects. The rest of
the manuscript is organised as follows: In the next section we describe and present the model. In Section 3 some analysis
of the model is carried out and some numerical simulations are carried out in Section 4. Finally, a discussion of our ﬁndings
is given at the end.
2. Model description
The model sub-divides the total population into the following sub-populations: susceptible males Sm(t), infected males
Im(t), susceptible straight women S f1 (t), infected straight women I f1 (t), susceptible lesbians S f2(t) and infected lesbians
I f2 (t). The total population is given by
N(t) = Nm(t) + N f1(t) + N f2(t), Nm(t) = Sm(t) + Im(t),
N f1(t) = S f1(t) + I f1(t), N f2(t) = S f2(t) + I f2(t) (1)
with Nm(t), N f1 (t) and N f2 (t) being the total number of males, straight females and lesbians, respectively. We assume that
once a woman becomes a lesbian she only engages in sexual encounters with women only. Susceptible humans enter the
population through birth at a rate Λ, a proportion ρ being males and the complementary proportion (1− ρ) entering the
straight females population. Here we further assume no woman is born as a lesbian (this is the authors’ assumption). Sus-
ceptible males acquire Trichomonas vaginalis following sexual contact with infected straight female at a rate λ f1 (t) =
β f1 I f1 (t)
N f1 (t)
where β f1 is the effective contact rate for Trichomonas vaginalis transmission from female to male. Susceptible straight fe-
males acquire Trichomonas vaginalis following sexual contact with an infected male at a rate λm(t) = βm Im(t)Nm(t) where βm is the
effective contact rate for Trichomonas vaginalis transmission from male to female. Lesbian females acquire Trichomonas vagi-
nalis following sexual contact with an infected lesbian where there is vulva to vulva sexual contact [20] or through sharing
unclean sexual toys at a rate λ f2 (t) =
β f2 I f2 (t)
N f2 (t)
where β f2 is the effective contact rate for Trichomonas vaginalis transmission
from lesbian to lesbian. The case of male to male sex transmitting Trichomonas vaginalis is not documented meaning they
are non-existent as far as the current literature is concerned. Upon getting infected the different susceptible groups move
into the corresponding infected classes, respectively. It is worth mentioning that some straight women become lesbians at
a rate α due to a number of factors, like (i) a broken and stressful love relationship with a member of the opposite sex,
(ii) peer pressure especially among teenagers among a host of other social factors. Infected individuals are treated at a rate
γ and move back into their corresponding susceptible classes. Individuals experience natural death at a rate μ. Trichomo-
niasis illness alone does not kill those suffering from it, so there is no disease induced death in this model. Based on these
assumptions the following system of differential equations describes the model:
S ′m(t) = ρΛ − μSm − λ f1 Sm + γ Im,
I ′m(t) = λ f1 Sm − (μ + γ )Im,
S ′f1(t) = (1− ρ)Λ − (μ + α)S f1 − λmS f1 + γ I f1 ,
I ′f1(t) = λmS f1 − (μ + α + γ )I f1 ,
S ′f2(t) = αS f1 − μS f2 − λ f2 S f2 + γ I f2 ,
I ′f2(t) = λ f2 S f2 + α I f1 − (μ + γ )I f2 . (2)
The model ﬂow diagram is shown in Fig. 1.
2.1. Model basic properties
In this section, we study the basic results of solutions of model system (2), which are essential in the proofs of stability
results.
Lemma 1. The equations preserve positivity of solutions.
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Proof. The vector ﬁeld given by the right-hand side of (2) points inward on the boundary of R6+ \{0}. For example, if Sm = 0
then S ′m = ρΛ + γ Im  0. All the other components are similar. 
Lemma 2. Each non-negative solution is bounded in L1-norm by max{N(0),Λ/μ}.
Proof. The norm L1-norm of each non-negative solution is N and it satisﬁes the inequality N ′ Λ − μN . Solutions to the
equation M ′ = Λ − μM are monotone increasing and bounded by Λ/μ if M(0) < Λ/μ. They are monotone decreasing and
bounded above if M(0)Λ/μ. Since N ′  M ′ the claim follows. 
Corollary 1. The region
Φ =
{
(Sm, Im, S f1 , I f1 , S f2 , I f2) ∈R6+: N 
Λ
μ
}
(3)
is invariant and attracting for system (2).
Theorem 1. For every non-zero, non-negative initial value, solutions of model system (2) exist for all times.
Proof. Local existence of solutions follows from standard arguments since the right-hand side of (2) is locally Lipschitz.
Global existence follows from the a priori bounds. 
3. Disease-free equilibrium and stability analysis
The disease-free equilibrium of model system (2), E0 is given by
E0 = (S0m, I0m, S0f1 , I0f1 , S0f2 , I0f2)= (ρΛμ ,0, (1− ρ)Λμ + α ,0, (1− ρ)Λαμ(μ + α) ,0
)
. (4)
Following [30], the effective reproduction number of model system (2) is given as
RT = max{RL, RN} =max
{
β f2
μ + γ ,
√
βmβ f1
(μ + γ )(μ + γ + α)
}
(5)
with RL being the number of secondary Trichomonas vaginalis infections caused by one infected lesbian in fully susceptible
population of lesbians in the presence of treatment and RN being the number of secondary Trichomonas vaginalis infections
caused by one infected male or female (non-lesbian) in a fully susceptible heterosexual population in the presence of
treatment. We now offer some analysis of the reproduction number. To that we have to know that the danger posed by
vagina to vagina contact is not the same as the one posed by penis to vagina penetration so β f2 = Aβm , A ∈ (0,1). The later
poses more risky, that is, heterosexual females are at an increased risk of getting infected than the lesbians. Thus, we write
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Parameter values used are in Table 2.
Fig. 3. Effects of varying infection and treatment rates on the reproduction number RN . Parameter values used are in Table 2.
RN =
√
βmβ f1
(μ + γ )(μ + γ + α) =
√
β f1 RL
A(μ + γ + α) ⇒
∂RL
∂RN
= 2ARN(μ + γ + α)
β f1
> 0. (6)
The fact that Eq. (6) is positive suggests that an increase in Trichomonas vaginalis cases among non-lesbians in the long
term translates to its increase among lesbians. This may be due to straight women (non-lesbians) becoming lesbians already
infected. This is further illustrated in Fig. 2.
In Fig. 3 different infection and treatment rates are analysed in an effort to get the ideal treatment rate for a particular
rate of infection.
Theorem 2 follows from [30].
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Using a theorem from [6], we show global stability when the reproduction number is less than unity.
Theorem 3. The disease-free equilibrium of system (2) is globally asymptotically stable provided RT < 1.
Proof. Following Castillo-Chavez et al. [6], we write system (2) in the form
X ′(t) = F (X, Y ),
Y ′(t) = G(X, Y ), G(X,0) = 0 (7)
where X = (Sm, S f1 , S f2 ) and Y = (Im, I f1 , I f2 ). Here, X ∈R3+ denotes (its components) the number of uninfected individuals
and Y ∈ R3+ denotes (its components) the number of infected individuals. The disease-free equilibrium is now denoted by
E0 = (X0,0) where X0 = ( ρΛμ , (1−ρ)Λμ+α , (1−ρ)Λαμ(μ+α) ). Here, we have to prove the two conditions:
(H1) For X ′(t) = F (X,0), X is globally asymptotically stable,
(H2) G(X, Y ) = UY − Ĝ(X, Y ), Ĝ(X, Y ) 0, for (X, Y ) ∈ Φ. (8)
Consider
F (X,0) =
[
ρΛ − μSm
(1− ρ)Λ − (μ + α)S f1
αS f1 − μS f2
]
,
U =
⎡⎢⎣−(μ + γ )
β f1ρ(μ+α)
μ(1−ρ) 0
βmμ(1−ρ)
ρ(μ+α) −(μ + γ + α) 0
0 α β f2 − (μ + γ )
⎤⎥⎦ and
Ĝ(X, Y ) =
[ Ĝ1(X, Y )
Ĝ2(X, Y )
Ĝ3(X, Y )
]
=
⎡⎢⎢⎣
β f1 I f1(
ρ(μ+α)
μ(1−ρ) − SmN f1 )
βmIm(
μ(1−ρ)
ρ(μ+α) −
S f1
Nm
)
β f2 I f2(1−
S f2
N f2
)
⎤⎥⎥⎦ . (9)
Clearly Ĝ3(X, Y ) is positive. Now we have to show that Ĝ1(X, Y ) and Ĝ2(X, Y ) are both positive. To do this we prove by
contradiction. Assume that statements in (10) are true
(i)
ρ(μ + α)
μ(1− ρ) <
Sm
N f1
and (ii)
μ(1− ρ)
ρ(μ + α) <
S f1
Nm
. (10)
From statement (i) in (10) we have that
N f1
Sm
<
μ(1−ρ)
ρ(μ+α) . Combining this with statement (ii) in (10) we have
N f1
Sm
<
μ(1− ρ)
ρ(μ + α) <
S f1
Nm
⇒ N f1
Sm
<
S f1
Nm
⇒ N f1Nm < S f1 Sm, (11)
a contradiction as statement (11) is not true. Thus,
N f1Nm  S f1 Sm ⇒
ρ(μ + α)
μ(1− ρ) 
Sm
N f1
and
μ(1− ρ)
ρ(μ + α) 
S f1
Nm
. (12)
Thus, Ĝ(X, Y ) 0. Therefore the disease-free equilibrium E0 is globally asymptotically stable. 
3.1. Existence and uniqueness of endemic equilibrium
The endemic equilibrium of model system (2) is given by E∗ = (S∗m, I∗m, S∗f1 , I∗f1 , S∗f2 , I∗f2 ) in terms of the forces of infec-
tion (λ∗m, λ∗f1 , λ
∗
f2
) where
S∗m =
ρΛ(μ + γ )
μ(μ + γ + λ f1∗)
, I∗m =
ρΛ
μ(μ + γ + λ f1∗)
, N∗m =
ρΛ
μ
, N∗f1 =
(1− ρ)Λ
μ + α , (13)
S∗f1 =
Λ(1− ρ)(μ + γ + α)
∗ , I
∗
f1
= Λ(1− ρ)λ
∗
m
∗ , (14)(μ + γ + α)(μ + α) + λm(μ + α) (μ + γ + α)(μ + α) + λm(μ + α)
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Number of possible positive roots of g(λ∗f2 ) = 0 for RL > 1 and RL < 1.
Cases A1 B1 C1 RL Number of sign changes No. of possible real roots
(endemic equilibrium)
1 + + − RL < 1 1 1
2 + − − RL > 1 1 1
S∗f2 =
αΛ(1− ρ)(γ (μ + γ + α + λ∗m) + (μ + γ + α)μ)
μ(μ + α)(μ + γ + λ∗f2)(μ + γ + α + λ∗m)
,
I∗f2 =
αΛ(1− ρ)(λ∗f2(μ + γ + α) + (μ + λ∗f2)λ∗m)
μ(μ + α)(μ + γ + λ∗f2)(μ + γ + α + λ∗m)
, N∗f2 =
(1− ρ)αΛ
μ(μ + α) . (15)
Substituting Eq. (13) into the equation of the force of infection λ∗m = βm I
∗
m
N∗m we obtain
λ∗m =
βmλ
∗
f1
μ + γ + λ∗f1
. (16)
Substituting Eq. (14) into the equation of the force of infection λ∗f1 =
β f1 I
∗
f1
N∗f1
we obtain
λ∗f1 =
β f1λ
∗
m
μ + γ + α + λ∗m . (17)
Substituting (16) into (17) we obtain
λ∗f1h
(
λ∗f1
)= λ∗f1(Aλ∗f1 + 1− R2N)= 0,
A = μ + γ + α + λ∗m. (18)
In Eq. (18) λ∗f1 = 0 corresponds to the disease-free equilibrium and λ∗f1 =
R2N−1
A and this exists when λ
∗
f1
> 0 ⇒ R2N > 1 ⇒
RN > 1 since the reproduction number is always positive. Substituting Eq. (15) into the equation for the force of infection
λ∗f2 =
β f2 I
∗
f2
N∗f2
we obtain
g
(
λ∗f2
)= A1λ∗2f2 + B1λ∗f2 + C1 = 0 where
A1 = 1
μ + γ , B1 = 1− RL, C1 = −
β f2μλ
∗
m
(μ + γ )(μ + γ + α + λ∗m) . (19)
It is worth mentioning that λ∗m like λ∗f1 exists only when RN > 1. Solving for λ∗f2 in g(λ∗f2 ) = 0, the roots of g(λ∗f2 ) = 0 are
explored using the Descartes rule of signs. The two possibilities are tabulated in Table 1.
The analysis of the results in Table 1 results in the following Theorem 4.
Theorem 4. The model system (2) has a unique endemic equilibrium if RT > 1 (RN > 1 and RL < 1 (Case 1)) and RT > 1 (RN > 1
and RL > 1 (Case 2)).
4. Numerical simulations
In this section, we carry out detailed numerical simulations using MatLab programming language to assess the effects of
Trichomonas vaginalis transmission in a community in the presence of treatment. The parameter values used for numerical
simulations are in Table 2.
Fig. 4 is a graphical representation showing what happens as we vary the infectives initial conditions when (a) there
is no treatment (RT > 1) and (b) there is treatment (RT < 1). It is shown that in the absence treatment (RT > 1) male
and female infectives increase until they reach their corresponding endemic equilibrium state. In the presence of treatment
as noted in Fig. 4(b), irregardless of the initial conditions, the infective populations (both male and female) decline to
asymptotically negligible levels signifying that treatment is able to control Trichomonas vaginalis infections. If that is the case
why does the world still experiencing the existence ofTrichomonas vaginalis infections? It seems people who are infected are
not presenting themselves for treatment or given that in most infected males it does not show any symptoms, so it is
possible that they may resist visiting clinics and doctors while continuously infecting their female sexual partners. This
suggests that more public health campaigns should be implemented to make males aware of their crucial role in the ﬁght
against Trichomonas vaginalis infections.
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Model parameters.
Model parameter Value (range) Source
Λ 0.029 yr−1 × 200000 [2]
μ 0.02 yr−1 [2]
βm 0.851 yr−1 [4]
β f1 0.451 yr
−1 [32]
β f2 0.25 yr
−1 Assumed
γ 0.90 yr−1 [12]
α 0.0125 yr−1 Assumed
ρ 0.505 [23]
Fig. 4. Simulations of the infectives for various initial conditions when (a) RT > 1 and (b) RT > 1 using parameter values in Table 2.
In Fig. 5 we show the effects of varying rates of Trichomonas vaginalis transmissibility on the infectives population.
In Figs. 5(a), (c) and (e) – effects of varying βm on males, straight females and lesbians, respectively. It is shown that
an increase in βm results in a pronounced increase in the number of females getting infected. However, an increase in
the number of females being infected leads to more males getting infected due to increased chances of an uninfected
male coming across an infected partner. The same happens in reverse order if β f1 is increased as shown in Figs. 5(b), (d)
and (f).
5. Discussion
This paper studies the dynamics of Trichomonas vaginalis transmission in a community taking into account the different
modes of transmission that is (i) penis to vagina/vagina to penis (between a male and a female through sex), (ii) vulva to
vulva among lesbian couples. The reproduction number of the model is computed and analysed in an effort to understand
the infection and ways to mitigate it. The disease-free equilibrium of the model is shown to be globally asymptotically stable
when the corresponding reproduction number is less than unity. Analysis of the reproduction number has shown that:
• The increase of trichomoniasis cases among non-lesbians also results a result in an increase of trichomoniasis cases
among lesbians. This might be due non-lesbians turning into lesbians while they are already infected. What does that
mean in terms of disease control in women? This simply suggests that control of Trichomonas vaginalis infections among
non-lesbians has a positive impact on lesbians as well.
• Ideal treatment rates for different infection rates have been explored and it is shown that the treatment has the poten-
tial to control trichomoniasis cases in any given community.
The analytical results obtained have also been supported by numerical simulations produced. It is noted from numerical
simulations that an increase in male (female) to female (male) transmission rate leads to an increase in Trichomonas vaginalis
infections among females (males). An increase of Trichomonas vaginalis infections among females translates to an increase
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of it among males in return and the triad cycle continues. How can this cycle be broken? It seems the problem lies with
the males given females experience some discomfort upon getting infected which forces them to seek treatment. When it
comes to males most of them do not experience any symptoms related to Trichomonas vaginalis infection and are most likely
to go untreated for a long period while continuously infecting females they come into sexual contact with. With regard to
Trichomonas vaginalis infections it may be the best to encourage all females infected to bring their sexual partners when
860 C.P. Bhunu, S. Mushayabasa / J. Math. Anal. Appl. 379 (2011) 852–860seeking treatment. Additionally, it may be necessary for relevant departments to step up health educational campaigns
advocating for regular reproductive health check up for males. This way asymptomatic Trichomonas vaginalis cases in males
may be found and treated. The study presented here is not exhaustive as it can be extended to include condom use as well
as co-infection with HIV.
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